Respiratory Insufficiency
Conditions
Brief summary
The effectiveness of NIV is clearly demonstrated but no recent studies describe the prescription based on clinical data and the conditions of using NIV at home according the various respiratory diseases. The investigators' purpose is that a better knowledge of NIV practices could improve both the quality to support patients at home and the efficacy of the treatment. The main objective of this study is to analyze the clinical data justifying the prescription of NIV advice according respiratory disease. The secondary objectives are to study comorbidities, treatment failures, survival rate during the study period.
Interventions
DEVICENon-invasive ventilation
Home NIV installation
Sponsors
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* No previous experience with domiciliary non-invasive ventilation * Adult patients, ≥ 18 years of age * Without tracheotomy * No evolutive cancer * No significant psychiatric disease * Possible medical monitoring
Exclusion criteria
* Evolutive cancer * Inability to understand rationale and/or consent form for study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical data leading to NIV device prescription | Day 1 | Age, blood gases, BMI, etiology, pulmonary function,comorbidities |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in blood gases | 4 months, 1 year and 2 years after inclusion | — |
| Change in the possible comorbidities | 4 months, 1 year and 2 years after inclusion | — |
| Treatment compliance | Initiation of treatment to 4 months | — |
| Hospitalizations | 4 months | During the study period all hospitalizations will be notify |
| Survival rate | 4 months | — |
Countries
France
Contacts
Primary ContactDidier FORET
Outcome results
None listed